Fluorodeoxyglucose F18
The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)
Positron-Emission Tomography
An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.
Radiopharmaceuticals
Tomography, Emission-Computed
Fluorine Radioisotopes
Multimodal Imaging
Tomography, X-Ray Computed
Sensitivity and Specificity
Glucose
Brain
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Predictive Value of Tests
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Whole Body Imaging
Fluorine
Neoplasm Staging
Nitrogen Radioisotopes
Magnetic Resonance Imaging
Carbon Radioisotopes
Gallium Radioisotopes
Tomography, Emission-Computed, Single-Photon
A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.
Gamma Cameras
Lymphatic Metastasis
Prospective Studies
Thallium Radioisotopes
Mediastinum
Sturge-Weber Syndrome
A non-inherited congenital condition with vascular and neurological abnormalities. It is characterized by facial vascular nevi (PORT-WINE STAIN), and capillary angiomatosis of intracranial membranes (MENINGES; CHOROID). Neurological features include EPILEPSY; cognitive deficits; GLAUCOMA; and visual defects.
F Factor
Prognosis
Solitary Pulmonary Nodule
Dobutamine
Image Processing, Computer-Assisted
Autoradiography
Treatment Outcome
F2-Isoprostanes
Retrospective Studies
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Neoplasm Recurrence, Local
Misonidazole
Hodgkin Disease
A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
Para-Aortic Bodies
Small masses of chromaffin cells found near the SYMPATHETIC GANGLIA along the ABDOMINAL AORTA, beginning cranial to the superior mesenteric artery (MESENTERIC ARTERY, SUPERIOR) or renal arteries and extending to the level of the aortic bifurcation or just beyond. They are also called the organs of Zuckerkandl and sometimes called aortic bodies (not to be confused with AORTIC BODIES in the THORAX). The para-aortic bodies are the dominant source of CATECHOLAMINES in the FETUS and normally regress after BIRTH.
Alzheimer Disease
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Incidental Findings
Unanticipated information discovered in the course of testing or medical care. Used in discussions of information that may have social or psychological consequences, such as when it is learned that a child's biological father is someone other than the putative father, or that a person tested for one disease or disorder has, or is at risk for, something else.
Reproducibility of Results
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
Neoplasm, Residual
Myocardial Revascularization
Radioisotopes
Soft Tissue Neoplasms
Follow-Up Studies
Carcinoma, Non-Small-Cell Lung
Tissue Distribution
Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios.
Lymphoma, Non-Hodgkin
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
False Positive Reactions
Neuroimaging
Subtraction Technique
Combination or superimposition of two images for demonstrating differences between them (e.g., radiograph with contrast vs. one without, radionuclide images using different radionuclides, radiograph vs. radionuclide image) and in the preparation of audiovisual materials (e.g., offsetting identical images, coloring of vessels in angiograms).
3-Iodobenzylguanidine
A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.
Diagnostic Imaging
Antineoplastic Combined Chemotherapy Protocols
Myocardium
Hexokinase
An enzyme that catalyzes the conversion of ATP and a D-hexose to ADP and a D-hexose 6-phosphate. D-Glucose, D-mannose, D-fructose, sorbitol, and D-glucosamine can act as acceptors; ITP and dATP can act as donors. The liver isoenzyme has sometimes been called glucokinase. (From Enzyme Nomenclature, 1992) EC 2.7.1.1.
Pleural Neoplasms
Preoperative Care
Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed)
Dideoxynucleosides
Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription.
Technetium Tc 99m Sestamibi
Carcinoma, Squamous Cell
Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. (1/3939)
OBJECTIVE: To determine the sensitivity, specificity, and accuracy of positron emission tomography with 2-fluorine-18-fluorodeoxyglucose (PET-FDG) in the preoperative staging (N and M staging) of patients with lung cancer. The authors wanted to compare the efficacy of PET scanning with currently used computed tomography (CT) scanning. MATERIALS AND METHODS: Results of whole-body PET-FDG imaging and CT scans were compared with histologic findings for the presence or absence of lymph node disease or metastatic sites. Sampling of mediastinal lymph nodes was performed using mediastinoscopy or thoracotomy. RESULTS: PET-FDG imaging was significantly more sensitive, specific, and accurate for detecting N disease than CT. PET changed N staging in 35% and M staging in 11% of patients. CT scans helped in accurate anatomic localization of 6/57 PET lymph node abnormalities. CONCLUSION: PET-FDG is a reliable method for preoperative staging of patients with lung cancer and would help to optimize management of these patients. Accurate lymph node staging of lung cancer may be ideally performed by simultaneous review of PET and CT scans. (+info)Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). (2/3939)
CD36 is a multifunctional, 88 kDa glycoprotein that is expressed on platelets and monocytes/macrophages. CD36 also has high homology with the long-chain fatty acid (LFA) transporter in the myocardium. Although platelet and monocyte CD36 levels can indicate a CD36 deficiency, they cannot predict specific clinical manifestations in the myocardium of a given person. We examined the hypothesis that a deficiency in LFA transport augments myocardial glucose uptake in patients with a type I CD36 deficiency. METHODS: Seven fasting patients with a type I CD36 deficiency and 9 controls were assessed by cardiac radionuclide imaging using beta-methyl-p-iodophenyl-pentadecanoic acid (BMIPP) as a LFA tracer and by PET with 18F-fluorodeoxyglucose (FDG). RESULTS: None of the patients with a CD36 deficiency showed myocardial uptake of BMIPP. The percentage dose uptake of BMIPP in these subjects was significantly lower than that in normal controls (1.31+/-0.24 versus 2.90+/-0.2; P < 0.005). PET studies revealed that myocardial FDG accumulation was substantially increased in patients with a CD36 deficiency. Quantitative analysis showed that the percentage dose uptake of FDG in patients with a CD36 deficiency was significantly higher than that in normal controls (1.28+/-0.35 versus 0.43+/-0.22; P< 0.01). CONCLUSION: CD36 functions as a major myocardial LFA transporter and its absence may cause a compensatory upregulation of myocardial glucose uptake. (+info)Detection of liver metastases from pancreatic cancer using FDG PET. (3/3939)
We evaluated the potential of the glucose analog [18F]fluorodeoxyglucose (FDG) as a PET tracer for the hepatic staging in 168 patients designated for resective pancreatic surgery. METHODS: Metastatic liver disease was confirmed or excluded during surgery or with CT follow-up for at least 6 mo. Proven metastases were then retrospectively identified on preoperative CT (gold standard). Hepatic PET scans of all patients were interpreted blindly. Any focal FDG uptake was considered malignant. Both proven hepatic metastases and suspicious hepatic PET lesions were then compared, lesion by lesion, with CT. Standardized uptake values (SUV) and tumor-to-liver ratios (T/L) were determined for the most intense lesion of each patient. RESULTS: Sensitivity of FDG PET was 68% (15 of 22 patients). The lesion detection rate was 97% (28 of 29 metastases) for lesions >1 cm and 43% (16 of 37 metastases) for lesions < or = 1 cm. Specificity was 95% (138 of 146 patients). Six of eight patients with false-positive results had marked intrahepatic cholestasis (versus 3 of 15 patients with true-positive lesions), one had an infrahepatic abscess and one had a right basal pulmonary metastasis. The SUV and T/L were 4.6+/-1.4 and 2.3+/-1.1, respectively, for malignant lesions and 4.1+/-1.5 and 1.9+/-0.3, respectively, for false-positive lesions and therefore are of limited value. CONCLUSION: FDG PET provides reliable hepatic staging for lesions >1 cm. False-positive results are associated with the presence of marked intrahepatic cholestasis. For lesions < or = 1 cm, FDG PET can define malignancy in 43% of suspicious CT lesions in the absence of dilated bile ducts. (+info)Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. (4/3939)
We have developed a new tumor-avid amino acid, 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC), labeled with 18F for nuclear medicine imaging. METHODS: [18F]FACBC was prepared with high specific activity (no carrier added [NCA]) and was evaluated for its potential in tumor localization. A comparative study was performed for [18F]FACBC and [18F]2-fluorodeoxyglucose (FDG) in which the uptake of each agent in 9L gliosarcoma (implanted intracerebrally in Fisher 344 rats) was measured. In addition, the first human PET study of [18F]FACBC was performed on a patient with residual glioblastoma multiforme. Quantitative brain images of the patient were obtained by using a Siemens 921 47-slice PET imaging system. RESULTS: In the rat brain, the initial level of radioactivity accumulation after injection of [18F]FACBC was low (0.11 percentage injected dose per gram [%ID/g]) at 5 min and increased slightly to 0.26 %ID/g at 60 min. The tumor uptake exhibited a maximum at 60 min (1.72 %ID/g), resulting in a tumor-to-brain ratio increase of 5.58 at 5 min to 6.61 at 60 min. In the patient, the uptake of [18F]FACBC in the tumor exhibited a maximum concentration of 146 nCi/mL at 35 min after injection. The uptake of radioactivity in the normal brain tissue was low, 21 nCi/mL at 15 min after injection, and gradually increased to 29 nCi/mL at 60 min after injection. The ratio of tumor to normal tissue was 6 at 20 min after injection. The [18F]FACBC PET scan showed intense uptake in the left frontal region of the brain. CONCLUSION: The amino acid FACBC can be radiofluorinated for clinical use. [18F]FACBC is a potential PET tracer for tumor imaging. (+info)Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice. (5/3939)
[18F]Fluorodeoxyglucose ([18F]FDG), a glucose analogue, has been widely used for tumor imaging. To investigate the mechanisms related to [18F]FDG uptake by tumors, an experiment involving nude mice was performed. METHODS: Human colon cancer cell lines SNU-C2A, SNU-C4 and SNU-C5 were transplanted to nude mice. Using immunohistochemical staining and Western blot, the expression of glucose transporter (Glut) isoforms (Glut-1 through -5) in xenografted tumors was analyzed. For the analysis of messenger ribonucleic acid (mRNA) expression, reverse-transcription polymerase chain reaction and Northern blot were used and the enzyme activity of hexokinase in cancer tissues was measured by continuous spectrophotometric rate determination. RESULTS: [18F]FDG uptake in SNU-C4 and SNU-C5 cells was higher than in normal colon cells. Among these cells and xenografted tumors, SNU-C5 showed the highest level of [18F]FDG uptake, followed by SNU-C4 and SNU-C2A. An immunostaining experiment showed intense staining of Glut-1 in SNU-C5 tumors but somewhat faint staining in SNU-C4. SNU-C5 tumors also showed positive staining with Glut-3, although this was not the case with SNU-C2A and SNU-C4. Western blot analysis showed the expression of Glut-1 and Glut-3 in all tumors. Experiments involving Northern blot analysis and reverse-transcription polymerase chain reaction confirmed the overexpression of Glut-1 mRNA in all tumors, with the highest level in SNU-C5. The level of Glut-3 mRNA was also elevated in SNU-C5 tumors but not in SNU-C2A and SNU-C4. The enzyme activity of hexokinase did not vary among different tumors. CONCLUSION: Gluts, especially Glut-1, are responsible for [18F]FDG uptake in a nude mouse model of colon cancer rather than hexokinase activity. Increased numbers of glucose transporters at the plasma membrane of cancer cells is attributed to an increased level of transcripts of glucose transporter genes and may be a cause of increased [18F]FDG uptake, at least in colon cancer tumors. (+info)Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients. (6/3939)
18-Fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) has previously been used successfully to image primary and metastatic breast cancer. In this pilot study, 19 breast cancer patients with symptoms/signs referrable to the brachial plexus were evaluated with 18FDG-PET. In 11 cases computerized tomography (CT) scanning was also performed. Of the 19 patients referred for PET study, 14 had abnormal uptake of 18FDG in the region of the symptomatic plexus. Four patients had normal PET studies and one had increased FDG uptake in the chest wall that accounted for her axillary pain. CT scans were performed in 9 of the 14 patients who had positive brachial plexus PET studies; six of these were either normal or showed no clear evidence of recurrent disease, while three CTs demonstrated clear brachial plexus involvement. Of two of the four patients with normal PET studies, one has had complete resolution of symptoms untreated while the other was found to have cervical disc herniation on magnetic resonance imaging (MRI) scan. The remaining two patients almost certainly had radiation-induced plexopathy and had normal CT, MRI and PET study. These data suggest that 18FDG-PET scanning is a useful tool in evaluation of patients with suspected metastatic plexopathy, particularly if other imaging studies are normal. It may also be useful in distinguishing between radiation-induced and metastatic plexopathy. (+info)Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. (7/3939)
We are developing quantitative assays to repeatedly and noninvasively image expression of reporter genes in living animals, using positron emission tomography (PET). We synthesized positron-emitting 8-[18F]fluoroganciclovir (FGCV) and demonstrated that this compound is a substrate for the herpes simplex virus 1 thymidine kinase enzyme (HSV1-TK). Using positron-emitting FGCV as a PET reporter probe, we imaged adenovirus-directed hepatic expression of the HSV1-tk reporter gene in living mice. There is a significant positive correlation between the percent injected dose of FGCV retained per gram of liver and the levels of hepatic HSV1-tk reporter gene expression (r2 > 0.80). Over a similar range of HSV1-tk expression in vivo, the percent injected dose retained per gram of liver was 0-23% for ganciclovir and 0-3% for FGCV. Repeated, noninvasive, and quantitative imaging of PET reporter gene expression should be a valuable tool for studies of human gene therapy, of organ/cell transplantation, and of both environmental and behavioral modulation of gene expression in transgenic mice. (+info)Reciprocal ST-segment depression associated with exercise-induced ST-segment elevation indicates residual viability after myocardial infarction. (8/3939)
OBJECTIVES: We evaluated the clinical significance of reciprocal ST-segment depression associated with exercise-induced ST-segment elevation for detecting residual viability within the infarcted area. BACKGROUND: Although the relation between residual viability and exercise-induced ST-segment elevation has been described, there are no reports focusing on the relation between myocardial viability and reciprocal ST-segment depression associated with exercise-induced ST-segment elevation. METHODS: We evaluated regional blood flow and glucose utilization using N-13 ammonia (NH3) and F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in 30 patients with a previous Q-wave myocardial infarction (anterior in 15, inferior in 15). All subjects had single-vessel disease and had exercise-induced ST-segment elevations (> or =1 mm) in electrocardiographic leads. RESULTS: Reciprocal ST-segment depression (> or =1 mm) was present in 16 patients (Group A; anterior in 6, inferior in 10) but not in the remaining 14 patients (Group B). The degree of exercise-induced ST-segment elevation (1.8+/-0.2 vs. 2.0+/-0.2 mm) and the time from the onset of infarction to the study (75+/-49 vs. 74+/-52 days) did not differ between groups. There were no significant differences between groups in the severity of left ventricular dysfunction and the residual luminal narrowing in the infarct-related artery (45+/-21 vs. 48+/-25%). The presence and site of infarction were confirmed by NH3-PET in all patients. FDG-PET demonstrated residual tissue viability within infarct-related area in all patients in Group A and in 3 (21%) of 14 patients in Group B (p < 0.01). The sensitivity, specificity and accuracy of reciprocal ST-segment depression associated with exercise-induced ST-segment elevation for detecting residual viability were 84%, 100% and 90%, respectively. CONCLUSIONS: The occurrence of reciprocal ST-segment depression associated with exercise-induced ST segment elevation in patients with a previous Q-wave infarction who had single-vessel disease indicates residual tissue viability within the infarct-related area. (+info)
Abstract 2435: Simvastatin Attenuates Plaque Inflammation- Evaluation by Fluorodeoxyglucose Positron Emission Tomography - |...
Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal...
Deep learning-based image quality improvement of 18 F-fluorodeoxyglucose positron emission tomography: a retrospective...
The Role of F18-fluorodeoxyglucose Positron Emission Tomography in the Management of Relapsed or Refractory Hodgkins Lymphoma ...
The Role of [[sup18]F]Fluorodeoxyglucose Positron Emission Tomography Imaging in the Evaluation of Hepatocellular Carcinoma
Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis -...
Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN...
Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG...
Correlation of (18)F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally...
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial...
DailyMed - FLUDEOXYGLUCOSE F 18- fludeoxyglucose f-18 injection
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical...
Laparoscopy, Computerised Tomogrpahy and Fluorodeoxyglucose Positron Emission Tomogrpahy Role in the Management of Gastric and...
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the...
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy...
Although 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) is a delicate modality - Current development of...
18F-Fluorodeoxyglucose Positron Emission Computer Tomography and Ultrasonography for Assessing Remission in Patients with...
18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors | Clinical...
Multifactorial Relationship Between F-18-Fluoro-Deoxy-Glucose Positron Emission Tomography Signaling and Biomechanical...
Prognostic Significance of Tumor Response as Assessed by Sequential {sup 18}F-Fluorodeoxyglucose-Positron Emission Tomography...
positron emission tomography Protocols and Video...
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in...
Keywords: 18F-fluorodeoxyglucose positron emission tomography - Suppression of KRas-mutant cancer through the combined...
Atypical spleen tuberculosis in a melanoma patient accidentally detected during a 18F‑FDG PET/CT study: Case report
Diagnostic Accuracy of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of the Primary Tumor in...
Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis-is it time to consider a new radiotracer?
Image findings of a rare case of gestational breast cancer diagnosed in a lactating woman with Fluorine‑18 fluorodeoxyglucose...
Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast...
Fallacy of Quantifying Lymphoma Activity by Scaling to the Liver in [F-18] Fluorodeoxyglucose Positron Emission Tomography ...
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission...
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective...
Plus it
Cortical hypometabolism assessed by a metabolic ratio in Parkinsons disease primarily reflects cognitive deterioration-[18F...
Print This Abstract
The effectiveness of dual-phase F-FDG PET/CT in the detection of epithelial ovarian carcinoma: a pilot study - Semantic Scholar
The prevalence and biomarkers characteristic of rapidly progressive Alzheimers disease from the Alzheimers Disease...
FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis | Journal of...
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal...
Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from...
Physiological F-FDG uptake patterns in female reproductive organs before and after chemotherapy treatments: assessment by PET/CT
Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules
Usefulness of 18F-FDG PET/CT in an Unusual Case of
Solid-Pseudopapillary Pancreatic Tumor in Childhood
With Aggressive Behavior...
String of pearls sign on FDG PET imaging in two patients with PUO of diverse etiologies and rare associations | Egyptian...
Staging of Breast Cancer with 18F-FDG PET and PET/CT | Bentham Science
Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point 18 F-FDG PET/CT...
Indian Journal of Nuclear Medicine : Table of Contents
Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas | EJNMMI...
Correlations of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging Parameters with the...
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic...
北京大学医学部机构知识库([email protected]): Tumor Volumes Measured From Static and Dynamic F-18-fluoro-2-deoxy-D-glucose Positron Emission...
A Prospective Comparison of 18F-FDG PET/CT and CT as Diagnostic Tools to Identify the Primary Tumor Site in Patients with...
Significance of <sup>18</sup> F-Fluorodeoxyglucose (FDG) Uptake in Response to...
Visual PET/CT scoring of mesenteric fdg uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis
YEUNGNAM UNIVERSITY: Incidental pituitary uptake on whole-body F-18-FDG PET/CT: a multicentre study
18</sup>Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy...
Dual time-point FDG PET/CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area
Sabinet | Dual time-point FDG PET/CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area ...
Primary and recurrent early stage laryngeal cancer: Preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose pet imaging<...
Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET/CT images<...
F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: Case series and literature review<...
F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas | Read by QxMD
OPUS Würzburg | Left Ventricular Diastolic Dysfunction in a Rat Model of Diabetic Cardiomyopathy using ECG-gated \(^{18}\)F-FDG...
Diagnosis of recurrent brain tumor: Value of <sup>201</sup>TI SPECT vs <sup>18</sup>F-...
Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkins disease | Radiation...
Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using 18F-FDG positron emission tomography: a...
OPUS Würzburg | Search
Studies offer mounting evidence that statins may reduce the risk of heart disease in people living with HIV | aidsmap
Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging - Danish National Research...
Abstract 2352: 18F-fluorodeoxyglucose PET Can Identify The Inflamed and Vulnerable Carotid Plaque - A Prospective Study in...
ORBi: Browsing ORBi
FDG PET/CT in Clinical Oncology - Ronan P. Killeen, Jasna Mihailovic, Stanley J. Goldsmith - Medicine
Molecular imaging provides a hint that Miller Fisher syndrome might involve the central nervous system | Journal of Neurology,...
Lymphoepithelial cyst mimicking pancreatic cancer: a case report and literature review | Surgical Case Reports | Full Text
The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance...
Diagnostic accuracy of 13 N-ammonia PET, 11 C-methionine PET and 18 F-fluorodeoxyglucose PET: a comparative study in patients...
Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation...
Print This Abstract
51 Drugstore: Dizziness levitra quality and trust!
Diagnostic delay in a case of T-cell neurolymphomatosis | BMJ Case Reports
Overnight Rx Store: Manicure russian band viagra shipping with airmail!
In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18 F-FDG PET/CT |...
The effect of fasting on Positron Emission Tomography (PET) imaging
Focus areas for increased utilization of pet/ct
Fujii, Soichiro - Author List - OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
Fujii, Soichiro - Author List - OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
F-18-FDG-PET/MRI in preoperative staging of oesophageal and gastroesophageal junctional cancer
Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a b3-Adrenergic Receptor Agonist |...
Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography. - Helen Wills...
Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors
18</sup>
F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic...
Radiopharmaceutical
F18-FDG (Fluorodeoxyglucose) Tumor imaging. Myocardial imaging IV In-vivo Imaging F18-Sodium Fluoride Bone imaging IV In-vivo ... F18-Fluorocholine Prostate tumor imaging IV In-vivo Imaging F18-Desmethoxyfallypride Dopamine receptor imaging IV In-vivo ...
Gelastic seizure
Positron Emission Tomography (PET-CT) using F-18 fluorodeoxyglucose (FDG) show reduced metabolism at the site of seizure onset ...
Positron emission tomography
The molecule most commonly used for this purpose is F-18 labeled fluorodeoxyglucose (FDG), a sugar, for which the waiting ... Together with NaF-F18, PET for bone imaging has been in use for 60 years for measuring regional bone metabolism and blood flow ... 18F-FDG is the most commonly used tracer for imaging muscles, and NaF-F18 is the most widely used tracer for imaging bones. PET ... For example, 18F-FDG is commonly used to detect cancer, NaF-F18 is widely used for detecting bone formation, and oxygen-15 is ...
Medical imaging
... creating F18-fluorodeoxyglucose, which can be used as a marker of metabolic utilization. Images of activity distribution ...
Positron emission tomography
PET scanning with the tracer fluorine-18 (F-18) fluorodeoxyglucose (FDG), called FDG-PET, is widely used in clinical oncology. ... The molecule most commonly used for this purpose is F-18 labeled fluorodeoxyglucose (FDG), a sugar, for which the waiting ... At present, however, by far the most commonly used radiotracer in clinical PET scanning is fluorodeoxyglucose (also called FDG ... PET has been widely used to image bacterial infections clinically by using fluorodeoxyglucose (FDG) to identify the infection- ...
List of MeSH codes (D09)
... fluorodeoxyglucose f18 MeSH D09.400.410.209 - galactolipids MeSH D09.400.410.420 - glycosphingolipids MeSH D09.400.410.420.025 ...
Fluorodeoxyglucose (18F)
"Fludeoxyglucose F 18- fludeoxyglucose f-18 injection". DailyMed. 8 May 2018. Retrieved 29 January 2020. "Fluorodeoxyglucose (F- ... Fluorodeoxyglucose (18F) (INN), or fluorodeoxyglucose F 18 (USAN and USP), also commonly called fluorodeoxyglucose and ... July 1980). "A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection". ...
Standardized uptake value
Its use is particularly common in the analysis of [18F]fluorodeoxyglucose ([18F]FDG) images of cancer patients. It can also be ... the SUV concept had only begun to be tested for other radiotracers such as fluorothymidine F-18 ([18F]FLT) and conclusions on ... Functional imaging Medical imaging Positron emission tomography Fluorodeoxyglucose Multi-compartment model Patlak plot ...
Positron emission tomography
PET scanning with the tracer fluorine-18 (F-18) fluorodeoxyglucose (FDG), called FDG-PET, is widely used in clinical oncology. ... The molecule most commonly used for this purpose is F-18 labeled fluorodeoxyglucose (FDG), a sugar, for which the waiting ... Some radioactive tracers used for Alzheimer's are florbetapir F18, flutemetamol F18, and florbetabenF18, which are all used to ... At present,[when?] by far the most commonly used radiotracer in clinical PET scanning is fluorodeoxyglucose (also called FDG or ...
Sandip Basu
Basu S, Nair N, Banavali S (2007). "Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal ... F-18]fluoro-D-glucose-positron emission tomography: a novel application with significant implications for combined structure- ... fluorodeoxyglucose positron emission tomography in this setting". J Clin Oncol. 25 (10): 1297, author reply 1297-9. doi:10.1200 ... progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron ...
Abass Alavi
Martin Reivich-were the first scientists to conceive the idea of labeling deoxyglucose with positron-emitting fluroide (F-18), ... Fluorodeoxyglucose (FDG). Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research ...
Brain positron emission tomography
Some radioactive tracers used for Alzheimer's are florbetapir 18F, flutemetamol F18, PiB and florbetaben 18F, which are all ... such as fluorodeoxyglucose (18F). The greatest benefit of PET scanning is that different compounds can show flow and oxygen, ...
Iodine-131
... (131I, I-131) is an important radioisotope of iodine discovered by Glenn Seaborg and John Livingood in 1938 at the University of California, Berkeley.[1] It has a radioactive decay half-life of about eight days. It is associated with nuclear energy, medical diagnostic and treatment procedures, and natural gas production. It also plays a major role as a radioactive isotope present in nuclear fission products, and was a significant contributor to the health hazards from open-air atomic bomb testing in the 1950s, and from the Chernobyl disaster, as well as being a large fraction of the contamination hazard in the first weeks in the Fukushima nuclear crisis. This is because 131I is a major fission product of uranium and plutonium, comprising nearly 3% of the total products of fission (by weight). See fission product yield for a comparison with other radioactive fission products. 131I is also a major fission product of uranium-233, produced from thorium. Due to its mode of beta decay, ...
Fluorine
Chisté, V.; Bé, M. M. (2011). "F-18" (PDF). In Bé, M. M.; Coursol, N.; Duchemin, B.; Lagoutine, F.; et al. (eds.). Table de ... The most common tracer is fluorodeoxyglucose which, after intravenous injection, is taken up by glucose-requiring tissues such ...
Medical imaging
... creating F18-fluorodeoxyglucose, which can be used as a marker of metabolic utilization. Images of activity distribution ...
Fluorodeoxyglucose F18 | Harvard Catalyst Profiles | Harvard Catalyst
"Fluorodeoxyglucose F18" by people in Harvard Catalyst Profiles by year, and whether "Fluorodeoxyglucose F18" was a major or ... "Fluorodeoxyglucose F18" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... Below are the most recent publications written about "Fluorodeoxyglucose F18" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "Fluorodeoxyglucose F18". ...
Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]...
Fluorodeoxyglucose F18/pharmacokinetics*. *Glucose/metabolism. *Glucose Transporter Type 1. *Humans. *Ki-67 Antigen/metabolism* ... Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]- ... fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.. Kurokawa T1, Yoshida Y, Kawahara ...
Histopathologic correlates of degree of F-18 fluorodeoxyglucose uptake on PET in breast cancers
C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT
Home » Topics » Multiple Myeloma » Research » C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET ... More From BioPortfolio on "C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT". *Related ... C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT. 2014-08-27 04:00:36 , BioPortfolio ... F18-fluorodeoxyglucose(FDG).. Study Design. Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group ...
C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT - Full Text View - ClinicalTrials.gov
C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT (ACTMM). The safety and scientific ... C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT for Staging and Response Assessment. ... aimed to prospectively assess the clinical utility of ACT PET/CT in MM as compared to the commonly used F18-fluorodeoxyglucose( ...
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved...
Pre- and Posttreatment Findings of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Case of Acute...
oa Pre- and Posttreatment Findings of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Case of ... Pre- and Posttreatment Findings of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Case of Acute ... A case of acute Q fever hepatitis diagnosed by F-18 FDG PET/CT. Nucl Med Mol Imaging 46: 125-128. ...
F-18) Fluorodeoxyglucose Positron Emission Tomography as a Predictor of Pathologic Grade and Other Prognostic Variables in Bone...
F-18) Fluorodeoxyglucose Positron Emission Tomography as a Predictor of Pathologic Grade and Other Prognostic Variables in Bone ... F-18) Fluorodeoxyglucose Positron Emission Tomography as a Predictor of Pathologic Grade and Other Prognostic Variables in Bone ... F-18) Fluorodeoxyglucose Positron Emission Tomography as a Predictor of Pathologic Grade and Other Prognostic Variables in Bone ... F-18) Fluorodeoxyglucose Positron Emission Tomography as a Predictor of Pathologic Grade and Other Prognostic Variables in Bone ...
F-18]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle...
F-18]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle- ... The aim of this study was to evaluate the clinical use of [F-18]-fluorodeoxyglucose-positron emission tomography/computed ... The aim of this study was to evaluate the clinical use of [F-18]-fluorodeoxyglucose-positron emission tomography/computed ... The aim of this study was to evaluate the clinical use of [F-18]-fluorodeoxyglucose-positron emission tomography/computed ...
F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors | SpringerPlus | Full Text
F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors. *Masato Yoshioka1Email ... Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Padrazzoli S (2005) F-18-fluorodeoxyglucose positron emission ... F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology ... The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J ...
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective...
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective ... article{Ruers2002ValueOP, title={Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with ... Diagnostic and prognostic value of preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography for ...
IMPACT OF F-18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY BEFORE AND AFTER DEFINITIVE RADIATION THERAPY IN PATIENTS WITH...
F-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and...
... lymphoma of the breast and squamous cell cancer of the cervix that was detected and followed with F-18 fluorodeoxyglucose (FDG ... F-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and ... Kidd EA, Siegel BA, Dehdashti F, Grigsby PW: The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive ... Our patient was then referred for staging with F-18 FDG PET/CT that was acquired from base of skull to upper thigh with the CT ...
MSAC - 1357.1 - F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for the evaluation of breast cancer
Serial evaluation of increased chest wall F-18 fluorodeoxyglucose (FDG) uptake following radiation therapy in patients with...
Lowe, VJ, Hebert, ME, Anscher, MS & Coleman, RE 1998, Serial evaluation of increased chest wall F-18 fluorodeoxyglucose (FDG) ... Fingerprint Dive into the research topics of Serial evaluation of increased chest wall F-18 fluorodeoxyglucose (FDG) uptake ... keywords = "F-18 fluorodeoxyglucose (FDG), Lung neoplasms, Positron emission tomography (PET), Therapeutic radiology, Treatment ... Serial evaluation of increased chest wall F-18 fluorodeoxyglucose (FDG) uptake following radiation therapy in patients with ...
Fallacy of Quantifying Lymphoma Activity by Scaling to the Liver in [F-18] Fluorodeoxyglucose Positron Emission Tomography ...
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Circulation
F-18-Fluorodeoxyglucose-Positron Emission Tomography. The day after progenitor cell therapy, F-18-fluorodeoxyglucose-positron ... Quantitative F-18-fluorodeoxyglucose-positron emission tomography analysis revealed a significant (P,0.01) increase in ... The use of low-dose intravenous insulin in clinical myocardial F-18 FDG PET scanning. Clin Nucl Med. 1996; 21: 15-18. ... Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur ...
June 1995 - Volume 20 - Issue 6 : Clinical Nuclear Medicine
F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis mimicking peritoneal carcinomatosis<...
Hwang, J. H., Kim, S., & Lee, J. K. (2009). F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic ... Hwang, JH, Kim, S & Lee, JK 2009, F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis ... F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis mimicking peritoneal carcinomatosis. ... F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis mimicking peritoneal carcinomatosis. ...
March 2009 - Volume 34 - Issue 3 : Clinical Nuclear Medicine
F-18 Fluorodeoxyglucose PET/CT Findings in Active Hiccups. Yeatman, C Fitzhugh II; Minoshima, Satoshi ... Dual-Time F-18 FDG-PET/CT Imaging for Diagnosis of Occult Non-Hodgkin Lymphoma in a Patient With Esophageal Cancer. ... F-18 FDG PET-CT Imaging in Recurrent Cerebral Gliosarcoma. Ho, Linh Thuy; Wassef, Heidi; Henderson, Robert; More ... F-18 FDG-Avid Intrathyroidal Parathyroid Adenoma Mimicking Follicular Neoplasm. Kim, Mee Kyoung; Kim, Guil Sun; Kim, Su Yoen; ...
"Kluver-Bucy Syndrome"[mh] - PubMed - NCBI
Gallium-67 Scintigraphy and F-18 Fluorodeoxyglucose Position Emission Tomography in Posttransplant Lymphoproliferative Disorder...
Assessment of pulmonary neutrophi... preview & related info | Mendeley
... and may be quantified using 18-fluorodeoxyglucose positron emissi... ... Fluorodeoxyglucose F18. *Neutrophil. *α1-antitrypsin deficiency. Get free article suggestions today. Mendeley saves you time ... and may be quantified using 18-fluorodeoxyglucose positron emission tomography-computed tomography ((18)FDG PET-CT) as a ...
Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors -...
Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
Current version of study NCT01031875 on ClinicalTrials.gov
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance...
The Role of F18-fluorodeoxyglucose Positron Emission Tomography in the Management of Relapsed or Refractory Hodgkin's Lymphoma ...
The Role of F18-fluorodeoxyglucose Positron Emission Tomography in the Management of Relapsed or Refractory Hodgkins Lymphoma ... F18-fluorodeoxyglucose positron emission tomography (FDG-PET), commonly combined with computed tomography (CT), is widely used ... Home , News , The Role of F18-fluorodeoxyglucose Positron Emission Tomography in the Management of Relapsed or Refractory ... Palmer J, Goggins T, Broadwater G, et al., Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography ...
F-18 fluorodeoxyglucose positron emission tomography in an anorectal fistula with actinomycosis<...
指紋 深入研究「F-18 fluorodeoxyglucose positron emission tomography in an anorectal fistula with actinomycosis」主題。共同形成了獨特的指紋。 * ... F-18 fluorodeoxyglucose positron emission tomography in an anorectal fistula with actinomycosis. Chung-Huei Hsu, Chi-Ming Lee, ... Hsu, C-H., Lee, C-M., Chia, C. F., & Lin, Y-H. (2004). F-18 fluorodeoxyglucose positron emission tomography in an anorectal ... F-18 fluorodeoxyglucose positron emission tomography in an anorectal fistula with actinomycosis. / Hsu, Chung-Huei; Lee, Chi
Positron30
- Abdominal immune-related adverse events: detection on ultrasonography, CT, MRI and 18F-Fluorodeoxyglucose positron emission tomography. (harvard.edu)
- Prognostic Value of Preoperative Imaging: Comparing 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography to Computed Tomography Alone for Preoperative Planning in High-risk Histology Endometrial Carcinoma. (harvard.edu)
- Positron emission tomography combined with computed tomography using carbon-11 acetate (ACT PET/CT) may help detect lesions before treatment and evaluate response following therapy in patients with from multiple myeloma (MM). This study aimed to prospectively assess the clinical utility of ACT PET/CT in MM as compared to the commonly used F18-fluorodeoxyglucose(FDG). (clinicaltrials.gov)
- The aim of this study was to evaluate the clinical use of [F-18]-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in addition to conventional preoperative radiological investigations in a defined group of patients with high-risk muscle-invasive bladder cancer. (lu.se)
- Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. (semanticscholar.org)
- We report a case of a 46-year-old woman of unknown ethnic origin diagnosed with concurrent diffuse large B-cell lymphoma of the breast and squamous cell cancer of the cervix that was detected and followed with F-18 fluorodeoxyglucose (FDG) positron emission tomography and/or computed tomography (PET/CT). (biomedcentral.com)
- Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for s. (nih.gov)
- Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. (nih.gov)
- Hwang, JH , Kim, S & Lee, JK 2009, ' F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis mimicking peritoneal carcinomatosis ', International Journal of Gynecology and Obstetrics , vol. 104, no. 3, pp. 244-246. (elsevier.com)
- RATIONALE: Neutrophilic inflammation is understood to be of pathogenetic importance in chronic obstructive pulmonary disease (COPD) and may be quantified using 18-fluorodeoxyglucose positron emission tomography-computed tomography ((18)FDG PET-CT) as a noninvasive, spatially informative biomarker. (mendeley.com)
- F18-fluorodeoxyglucose positron emission tomography (FDG-PET), commonly combined with computed tomography (CT), is widely used in the initial evaluation and response assessment of patients with Hodgkin's lymphoma (HL). (touchoncology.com)
- F18-fluorodeoxyglucose positron emission tomography (FDG-PET) and functional magnetic resonance imaging (fMRI) were performed to gain a further insight in mechanisms underlying these visual sensations and to define a possible focus for therapeutic rTMS. (bmj.com)
- F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. (fredhutch.org)
- F18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a powerful tool to investigate the role of tumor metabolic activity and its suppression by therapy for cancer survival. (fredhutch.org)
- The purpose of this study was to estimate average radiation exposure from 18F-fluorodeoxyglucose (FDG) positron emission tomography /computed tomography ( PET /CT) examinations and to analyze possible factors affecting the radiation dose . (bvsalud.org)
- Although hepatoblastoma is the most common malign tumor in childhood in the liver there are few studies including fluorodeoxyglucose positron emission tomography/computed tomography imaging and hepatoblastoma. (scholarena.co)
- The role of [18F]fluorodeoxyglucose- positron emission tomography (FDG- PET ) in renal cell carcinoma remains to be clearly defined. (bvsalud.org)
- Detection of bone metastases in cancer-patients by F-18-fluoride and F-18-fluorodeoxyglucose positron emission tomography. (icr.ac.uk)
- The aim of this study is to compare the diagnostic efficiency of bone scintigraphy, fluorodeoxyglucose (FDG), and sodium fluoride (NaF) positron emission tomography/computed tomography (PET/CT) in the evaluation of bone metastasis of the several malignant tumors. (jbstjournal.com)
- Added value of using a cocktail of F-18 sodium fluoride and F-18 fluorodeoxyglucose in positron emission tomography/computed tomography for detecting bony metastasis: A case report. (jbstjournal.com)
- Fluorodeoxyglucose (18F) (INN), or fluorodeoxyglucose F 18 (USAN and USP), also commonly called fluorodeoxyglucose and abbreviated [18F]FDG, 18F-FDG or FDG, is a radiopharmaceutical used in the medical imaging modality positron emission tomography (PET). (wikipedia.org)
- PURPOSE: Fluorine-18-fluorodeoxyglucose-positron emission tomography (FDG-PET) hypometabolism has been used to localize the epileptogenic zone. (biomedsearch.com)
- Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, Kumita S. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. (springer.com)
- During the past several years, it has become quite evident that positron emission tomography (PET) with 18 F-fluorodeoxyglucose (FDG) imaging can play a major role in the management of patients with suspected infection. (asm.org)
- The concept of positron emission tomography (PET) with 18 F-fluorodeoxyglucose (FDG) was born in 1973, when the feasibility of radiolabeling deoxyglucose (DG), a glucose analogue, for in vivo imaging purposes was proposed. (asm.org)
- F-18 fluorodeoxyglucose positron emission tomography in pulmonary cryptococcoma. (bmj.com)
- This prospective study evaluated the prognostic significance of 18 F-fluorodeoxyglucose ( 18 F-FDG) uptake in primary non-small cell lung cancer (NSCLC) at positron emission tomography, in a carefully staged population, while correcting for partial volume effects. (aacrjournals.org)
- Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning? (nii.ac.jp)
- The purpose is to evaluate the accuracy of integrated 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography ((CT) with intravenous contrast medium in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer, with surgical and histopathological findings used as the reference standard. (semanticscholar.org)
- Positron Emission Tomography (PET-CT) using F-18 fluorodeoxyglucose (FDG) show reduced metabolism at the site of seizure onset. (wikipedia.org)
Uptake2
- Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positr. (nih.gov)
- Myocardial F-18 fluorodeoxyglucose uptake (during hyperinsulinemic glucose clamping) was compared with rest perfusion assessed with early thallium-201 SPECT. (nih.gov)
Computed tomography1
- Recently, fluorine-18 (F-18) fluorodeoxyglucose in combination with single-photon emission computed tomography (SPECT) has been proposed to identify viable myocardium, Thallium-201 reinjection and low dose dobutamine echocardiography are used routinely for this purpose. (nih.gov)
Myocardial1
- 18F-fluorodeoxyglucose (FDG) has been useful in the evaluation of myocardial inflammatory processes. (springer.com)
Fluorine-18 fluorodeoxyglucose1
- Fluorine-18 fluorodeoxyglucose/thallium-201 SPECT was superior to the other techniques in assessing functional recovery. (nih.gov)
Tumor1
- Fluorodeoxyglucose-PET may identify residual viable tumor when it is otherwise undetectable. (elsevier.com)
Thallium-2012
Colorectal1
- The purpose of this study was to evaluate the association of F-18-fluorodeoxyglucose (FDG)-PET/CT findings with the vascular endothelial growth factor (VEGF) family and its receptor (VEGFR) levels in metastatic and nonmetastatic colorectal cancer (CRC). (istanbulc.edu.tr)
Findings1
- It is important to remember that not all abnormalities on a fluorodeoxyglucose PET scan are due to malignancy, and unexpected findings may need to be evaluated further. (nps.org.au)
MeSH1
- Fluorodeoxyglucose F18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (harvard.edu)
Imaging2
- Fluorodeoxyglucose PET has had a major impact on the management of a broad range of malignancies because it is more sensitive than conventional imaging modalities. (nps.org.au)
- PET imaging with fluorodeoxyglucose (FDG) is now widely available as an accurate staging tool for NSCLC ( 7 , 8 ). (aacrjournals.org)
Radiotracer2
- The main radiotracer in clinical use is F-18 fluorodeoxyglucose. (nps.org.au)
- The most common radiotracer is F-18 fluorodeoxyglucose (FDG), a molecule similar to glucose. (radiologyinfo.org)
Scan1
- PET F-18 FDG (fluorodeoxyglucose) scan. (ahealthyme.com)
Liver1
- 18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver. (scholarena.co)
Commonly1
- multiple myeloma (MM). This study aimed to prospectively assess the clinical utility of ACT PET/CT in MM as compared to the commonly used F18-fluorodeoxyglucose(FDG). (bioportfolio.com)
Bone1
- The bone agent, F-18-fluoride and the tumour agent F-18-fluorodeoxyglucose, have been used to evaluate both benign and malignant skeletal disorders qualitatively and quantitatively and the current knowledge with respect to the skeleton in cancer patients is summarised in this article. (icr.ac.uk)
Role1
- 2013) Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDG-PET in Treatment Planning. (omicsonline.org)
Major1
- This graph shows the total number of publications written about "Fluorodeoxyglucose F18" by people in Harvard Catalyst Profiles by year, and whether "Fluorodeoxyglucose F18" was a major or minor topic of these publication. (harvard.edu)
Comparison1
- Comparison of F-18-fluorodeoxyglucose PE. (istanbulc.edu.tr)
Important1
- F-18-fluorodeoxyglucose (FDG)-PET is being used but has important limitations. (innovations-report.com)
Diagnostic1
- 40 ccr 37 a9552 fluorodeoxyglucose f18 fdg, diagnos ccr x 37 a9580 sodium fluoride f 18,diagnostic. (pdsasa.co.za)
Suggests1
- CONCLUSIONS: Our preliminary experience suggests that F-fluorodeoxyglucose PET/CT may be clinically beneficial in evaluating fever of unknown origin in children with complicated underlying diseases mandating intensive support in ICUs if usual investigative methods are unsuccessful. (picujournalclub.com)
Intensive1
- PATIENTS: Nineteen critically ill children (mean age, 5.7 yr old) with complicated underlying diseases requiring intensive care support underwent F-fluorodeoxyglucose PET/CT to evaluate fever of unknown origin. (picujournalclub.com)
Diagnosis2
- PURPOSE: We aim to report the quality of accuracy studies investigating the utility of [18F]fluorodeoxyglucose (FDG)-PET in supporting the diagnosis of prodromal Alzheimer's Disease (AD), frontotemporal lobar degeneration (FTLD) and prodromal dementia with Lewy bodies (DLB) in mild cognitive impairment (MCI) subjects, and the corresponding recommendations made by a panel of experts. (elsevier.com)
- MEASUREMENTS AND MAIN RESULTS: The F-fluorodeoxyglucose PET/CT findings (blinded to the final clinical diagnosis) were compared with final histopathology, culture, serology results, or follow-up imaging. (picujournalclub.com)
Patients2
- Here, we report our preliminary experience using F-fluorodeoxyglucose PET/CT in this specific group of patients. (picujournalclub.com)
- In the other two patients where F-fluorodeoxyglucose PET/CT also showed negative findings, fever subsided shortly thereafter without treatment. (picujournalclub.com)
Evaluation1
- However, there are limited studies about the role of F-fluorodeoxyglucose PET/CT in evaluation of fever of unknown origin in critically ill children, especially those presenting with complicated underlying diseases under treatment. (picujournalclub.com)
Studies1
- We evaluated the performance of CD-Well in in vitro measurement and in vivo 18 F-fluorodeoxyglucose and [ 11 C]2-carbomethoxy-3β-(4- fluorophenyl) tropane studies. (fujita-hu.ac.jp)